SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950005-00-000249
Filing Date
2000-02-14
Accepted
2000-02-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT 1 TO SCHEDULE 13D SC 13D/A 34786
  Complete submission text file 0000950005-00-000249.txt   36660
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45671 | Film No.: 537651
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 2180 SAND HILL ROAD SUITE 300 MENLO PARK CA 94025
Business Address 2180 SAND HILL ROAD SUITE 300 MENLO PARK CA 94025 4158549080
U S VENTURE PARTNERS IV L P (Filed by) CIK: 0001030241 (see all company filings)